FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to obstetrics and gynecology, and is intended to predict the effectiveness of treatment of moderate preeclampsia, including in women with chronic arterial hypertension, starting from 24 weeks of pregnancy. In pregnant women up to 36 weeks of gestation, the relative content of CD20-CD38 + in the population of CD19 + B-lymphocytes is determined. If its value is more than 2.8%, a positive effect of the treatment of moderate preeclampsia is predicted. With a value of 2.8% or less, no positive effect from the treatment of moderate preeclampsia is predicted.
EFFECT: invention provides an expansion of the arsenal of tools for predicting effectiveness of treatment of moderate preeclampsia.
1 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE TREATMENT OF MODERATE PREECLAMPSIA | 2019 |
|
RU2705374C1 |
| METHOD FOR PREDICTION OF CEREBRAL ISCHEMIA IN NEWBORNS BORN TO MOTHERS WITH PREECLAMPSIA | 2023 |
|
RU2819655C1 |
| METHOD FOR FORECASTING SEVERITY OF EARLY PREECLAMPSY | 2021 |
|
RU2753463C1 |
| METHOD OF DIAGNOSTICS OF PREECLAMPSIA ATTACHMENT IN PREGNANT WOMEN WITH CHRONIC ARTERIAL HYPERTENSION | 2016 |
|
RU2652447C1 |
| METHOD FOR DIAGNOSING SEVERITY OF PREECLAMPSIA WITH UNDERLYING CHRONIC ARTERIAL HYPERTENSION IN PREGNANT WOMEN | 2023 |
|
RU2815220C1 |
| METHOD FOR PREDICTION OF RISK OF PREECLAMPSIA IN WOMEN WITH CHRONIC ARTERIAL HYPERTENSION | 2018 |
|
RU2699974C1 |
| METHOD FOR PREDICTING CEREBRAL ISCHEMIA IN NEWBORNS BORN TO MOTHERS WITH PREECLAMPSIA | 2021 |
|
RU2777225C1 |
| METHOD OF DIAGNOSTICS OF SEVERITY OF PRE-ECLAMPSIA ON THE BACKGROUND OF CHRONIC ARTERIAL HYPERTENSION IN PREGNANT WOMEN | 2023 |
|
RU2804645C1 |
| METHOD FOR PREDICTING CLINICAL EFFECTIVENESS IN SEVERE GESTOSES | 2008 |
|
RU2377569C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF ISOLATED PREECLAMPSIA AND PREECLAMPSIA, DEVELOPING ON THE BACKGROUND OF UNDIAGNOSED CHRONIC ARTERIAL HYPERTENSION | 2019 |
|
RU2713436C1 |
